drugset / Trial / NCT06985589

Efficacy and Safety of Fire Needle Therapy Combined With Cortex Phellodendri Compound Fluid Wet Compress for Acute Herpes Zoster: a Randomized Controlled Trial.

NCT06985589

RandomizedParallel-groupSingle-blindTreatment

Summary

Herpes zoster (HZ) results from a reactivation of varicella-zoster virus (VZV), which causes primary infection leading to chickenpox and remains latent in the ganglia. Fire needle therapy is a non-pharmacological treatment that combines heat therapy with traditional acupuncture. This technique involves heating sterilized needles and swiftly inserting them into specific points or areas of the skin. Chinese herbal wet compress therapy is directly delivering medications to the lesion site, facilitating rapid transdermal absorption. This method ensures stable local drug concentrations and effectively alleviates pain, swelling, and other clinical symptoms. In this study, we conducted a randomized controlled trial to evaluate the clinical efficacy and safety of fire needle therapy combined with CPCF wet compress for the treatment of acute HZ. 32 acute HZ patients were randomized into control (standard antiviral and analgesic therapy) and treated groups (standard therapy plus fire needle \[5 sessions, every other day\] and CPCF wet compress \[3 times/day, 10 days\]). After 10 days of treatment, fire needle combined with CPCF wet compress significantly enhances symptom relief, pain reduction, and quality of life in acute HZ, with favorable safety.

Timeline

Start
2024-01-01
Primary completion
2024-08-31
Completion
2024-08-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Cortex Phellodendri compound fluid Traditional medicine (herbal / TCM) Topical
Background Penciclovir Small molecule 0.5 g Intravenous
Background Pregabalin Small molecule 75 mg Oral
Background methylcobalamin Small molecule 0.5 mg Oral

Indications